📰 Proprietary Technologies News
Proprietary Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Proprietary Technologies. Real-time updates on events, politics, business and more.
December 17, 2023
In a significant move within the pharmaceutical industry, CEO Michael Castagna has parted with a substantial number of shares in MannKind Corp (NASDAQ:MNKD).
September 25, 2023
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced that its exclusively licensed induced pluripotent stem cell (iPSC)-based technology has been granted a patent by the China National Intellectual Property Administration (CNIPA).
August 30, 2023
It has been a busy past few months for Australian battery recycling technology startup Battery Pollution Technologies.
June 30, 2023
More Than 600 Bispecific, Trispecific & Tetra Specific Antibodies Are In Clinical Trials Says Kuick Research In New Reports...
June 16, 2023
This article outlines the essential steps on how to start an IT consulting business. Read on to learn how to start a consulting business.
May 25, 2023
Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Companies & Market Trends Insight 2023 Report Highlights: Global Tetraspecific
April 3, 2023
Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Companies & Market Trends Insight 2023 Report Highlights: Global
March 30, 2023
Pioneering Differentiated TCR-T Therapies for Cancer Patients FY 2022 Financial Results and Corporate Update Forward Looking... | March 30, 2023
March 28, 2023
/PRNewswire/ -- The "Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Companies & Market Trends Insight 2023" report has been added to...
March 23, 2023
Report Highlights:. • Global Tetraspecific Clinical Trials Landscape Insight. ...